Journal articles on the topic 'Inhibiteurs de JAK/STAT'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Inhibiteurs de JAK/STAT.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
El Jammal, Thomas, Mathieu Gerfaud-Valentin, Pascal Seve, and Yvan Jamilloux. "Inhibiteurs de la signalisation JAK/STAT au cours des maladies rhumatologiques : un spectre grandissant." Revue du Rhumatisme 87, no. 4 (July 2020): 261–72. http://dx.doi.org/10.1016/j.rhum.2020.01.032.
Sagez, F., M. Sawaf, J. Sibilia, H. Dumortier, F. Monneaux, and J. E. Gottenberg. "Nouveau mécanisme d’action des inhibiteurs de la voie JAK/STAT : l’inhibition de la différenciation et de la fonction des lymphocytes T folliculaires auxiliaires." Revue du Rhumatisme 83 (November 2016): A215. http://dx.doi.org/10.1016/s1169-8330(16)30522-1.
Colonne, Punsiri M., Marina E. Eremeeva, and Sanjeev K. Sahni. "Beta Interferon-Mediated Activation of Signal Transducer and Activator of Transcription Protein 1 Interferes with Rickettsia conorii Replication in Human Endothelial Cells." Infection and Immunity 79, no. 9 (June 20, 2011): 3733–43. http://dx.doi.org/10.1128/iai.05008-11.
Barry, Sean P. "JAK-STAT." JAK-STAT 1, no. 2 (April 2012): 90–91. http://dx.doi.org/10.4161/jkst.20939.
Galli Sanchez, Ana Paula, Tatiane Ester Aidar Fernandes, and Gustavo Martelli Palomino. "The JAK-STAT Pathway and the JAK Inhibitors." Journal of Clinical Research in Dermatology 7, no. 5 (November 30, 2020): 1–6. http://dx.doi.org/10.15226/2378-1726/7/5/001128.
Minaudo, Carla. "Vía JAK-STAT e inhibidores JAK." Dermatología Argentina 28, no. 2 (June 1, 2022): 55–62. http://dx.doi.org/10.47196/da.v28i2.2324.
Liu, Jia, Faping Wang, and Fengming Luo. "The Role of JAK/STAT Pathway in Fibrotic Diseases: Molecular and Cellular Mechanisms." Biomolecules 13, no. 1 (January 6, 2023): 119. http://dx.doi.org/10.3390/biom13010119.
Mirault, Tristan. "Risques cardiovasculaires des inhibiteurs de JAK." JMV-Journal de Médecine Vasculaire 47 (March 2022): S40. http://dx.doi.org/10.1016/j.jdmv.2022.01.015.
Schieler, Jarod M., and Jeffrey O. Henderson. "Treating a Dysregulated JAK/STAT Pathway in Cancer Cells." Journal of Student Research 5, no. 1 (April 14, 2016): 11–17. http://dx.doi.org/10.47611/jsr.v5i1.282.
Zhan, Xinliang, Yan Wang, and Jing Yang. "Janus Kinase/Signal Converters, and the Transcriptional Activator Signaling Pathway Promotes Lung Cancer Through Increasing M2 Macrophage." Journal of Biomaterials and Tissue Engineering 11, no. 4 (April 1, 2021): 605–11. http://dx.doi.org/10.1166/jbt.2021.2566.
Harrison, D. A. "The JAK/STAT Pathway." Cold Spring Harbor Perspectives in Biology 4, no. 3 (March 1, 2012): a011205. http://dx.doi.org/10.1101/cshperspect.a011205.
Wells, William A. "A JAK/STAT invasion." Journal of Cell Biology 156, no. 3 (January 28, 2002): 413. http://dx.doi.org/10.1083/jcb1563rr2.
Aaronson, D. S., and C. M. Horvath. "The JAK-STAT Pathway." Science Signaling 2003, no. 197 (August 26, 2003): cm11. http://dx.doi.org/10.1126/stke.2003.197.cm11.
Myllymäki, H., and M. Rämet. "JAK/STAT Pathway inDrosophilaImmunity." Scandinavian Journal of Immunology 79, no. 6 (May 21, 2014): 377–85. http://dx.doi.org/10.1111/sji.12170.
Imada, Kazuroni, and Warren J. Leonard. "The Jak-STAT pathway." Molecular Immunology 37, no. 1-2 (January 2000): 1–11. http://dx.doi.org/10.1016/s0161-5890(00)00018-3.
Ladyman, Sharon R., and David R. Grattan. "JAK-STAT and feeding." JAK-STAT 2, no. 2 (April 2013): e23675. http://dx.doi.org/10.4161/jkst.23675.
Hombría, James Castelli-Gair, and Sol Sotillos. "JAK-STAT pathway inDrosophilamorphogenesis." JAK-STAT 2, no. 3 (July 15, 2013): e26089. http://dx.doi.org/10.4161/jkst.26089.
Mertens, Claudia, and James E. Darnell. "SnapShot: JAK-STAT Signaling." Cell 131, no. 3 (November 2007): 612–612. http://dx.doi.org/10.1016/j.cell.2007.10.033.
Valle-Mendiola, Arturo, Adriana Gutiérrez-Hoya, and Isabel Soto-Cruz. "JAK/STAT Signaling and Cervical Cancer: From the Cell Surface to the Nucleus." Genes 14, no. 6 (May 24, 2023): 1141. http://dx.doi.org/10.3390/genes14061141.
Rodriguez, Irasema, and Kate J. F. Carnevale. "Systematic Review: JAK-STAT Regulation and Its Impact on Inflammation Response in ARDS from COVID-19." Immuno 4, no. 2 (May 14, 2024): 147–58. http://dx.doi.org/10.3390/immuno4020010.
Park, Hyunjung, Sangjik Lee, Jaehun Lee, Hyuk Moon, and Simon Weonsang Ro. "Exploring the JAK/STAT Signaling Pathway in Hepatocellular Carcinoma: Unraveling Signaling Complexity and Therapeutic Implications." International Journal of Molecular Sciences 24, no. 18 (September 6, 2023): 13764. http://dx.doi.org/10.3390/ijms241813764.
Montero, Paula, Javier Milara, Inés Roger, and Julio Cortijo. "Role of JAK/STAT in Interstitial Lung Diseases; Molecular and Cellular Mechanisms." International Journal of Molecular Sciences 22, no. 12 (June 9, 2021): 6211. http://dx.doi.org/10.3390/ijms22126211.
Damerau, Alexandra, Timo Gaber, Sarah Ohrndorf, and Paula Hoff. "JAK/STAT Activation: A General Mechanism for Bone Development, Homeostasis, and Regeneration." International Journal of Molecular Sciences 21, no. 23 (November 26, 2020): 9004. http://dx.doi.org/10.3390/ijms21239004.
Gouverneur, A., J. Avouac, C. Prati, J. L. Cracowski, T. Schaeverbeke, A. Pariente, and M. E. Truchetet. "Inhibiteurs de JAK et risque de cancer." Revue du Rhumatisme 89 (December 2022): A69—A70. http://dx.doi.org/10.1016/j.rhum.2022.10.094.
Neeli, Indira, Zhimin Liu, Nagadhara Dronadula, Z. Alex Ma, and Gadiparthi N. Rao. "An Essential Role of the Jak-2/STAT-3/Cytosolic Phospholipase A2Axis in Platelet-derived Growth Factor BB-induced Vascular Smooth Muscle Cell Motility." Journal of Biological Chemistry 279, no. 44 (August 22, 2004): 46122–28. http://dx.doi.org/10.1074/jbc.m406922200.
Gorissen, Marnix, Erik de Vrieze, Gert Flik, and Mark O. Huising. "STAT genes display differential evolutionary rates that correlate with their roles in the endocrine and immune system." Journal of Endocrinology 209, no. 2 (February 17, 2011): 175–84. http://dx.doi.org/10.1530/joe-11-0033.
Gerds, Aaron T. "Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN." Hematology 2019, no. 1 (December 6, 2019): 407–14. http://dx.doi.org/10.1182/hematology.2019000048.
Jain, Mayank, Mukul Kumar Singh, Hari Shyam, Archana Mishra, Shailendra Kumar, Ambrish Kumar, and Jitendra Kushwaha. "Role of JAK/STAT in the Neuroinflammation and its Association with Neurological Disorders." Annals of Neurosciences 28, no. 3-4 (July 2021): 191–200. http://dx.doi.org/10.1177/09727531211070532.
Karati, Dipanjan, Kakasaheb Ramoo Mahadik, Piyush Trivedi, and Dileep Kumar. "The Emerging Role of Janus Kinase Inhibitors in the Treatment of Cancer." Current Cancer Drug Targets 22, no. 3 (March 2022): 221–33. http://dx.doi.org/10.2174/1568009622666220301105214.
Wahnschaffe, Linus, Till Braun, Sanna Timonen, Anil K. Giri, Alexandra Schrader, Prerana Wagle, Henrikki Almusa, et al. "JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL." Cancers 11, no. 12 (November 21, 2019): 1833. http://dx.doi.org/10.3390/cancers11121833.
Owen, Katie L., Natasha K. Brockwell, and Belinda S. Parker. "JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression." Cancers 11, no. 12 (December 12, 2019): 2002. http://dx.doi.org/10.3390/cancers11122002.
Gutiérrez-Hoya, Adriana, and Isabel Soto-Cruz. "Role of the JAK/STAT Pathway in Cervical Cancer: Its Relationship with HPV E6/E7 Oncoproteins." Cells 9, no. 10 (October 15, 2020): 2297. http://dx.doi.org/10.3390/cells9102297.
Pazdrak, K., S. Stafford, and R. Alam. "The activation of the Jak-STAT 1 signaling pathway by IL-5 in eosinophils." Journal of Immunology 155, no. 1 (July 1, 1995): 397–402. http://dx.doi.org/10.4049/jimmunol.155.1.397.
Li, Boheng, Qin Wan, Zhubo Li, and Wee-Joo Chng. "Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers." Cancers 13, no. 20 (October 14, 2021): 5147. http://dx.doi.org/10.3390/cancers13205147.
Li, Boheng, Qin Wan, Zhubo Li, and Wee-Joo Chng. "Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers." Cancers 13, no. 20 (October 14, 2021): 5147. http://dx.doi.org/10.3390/cancers13205147.
Serbina, Inessa Mykhailivna, and Yu S. Ovcharenko. "JANUS KINASE INHIBITORS IN DERMATOLOGY: PRESENT AND FUTURE." International Medical Journal, no. 4(108) (December 10, 2021): 70–76. http://dx.doi.org/10.37436/2308-5274-2021-4-13.
Moser, Bernhard, Sophie Edtmayer, Agnieszka Witalisz-Siepracka, and Dagmar Stoiber. "The Ups and Downs of STAT Inhibition in Acute Myeloid Leukemia." Biomedicines 9, no. 8 (August 19, 2021): 1051. http://dx.doi.org/10.3390/biomedicines9081051.
Roger, Inés, Javier Milara, Paula Montero, and Julio Cortijo. "The Role of JAK/STAT Molecular Pathway in Vascular Remodeling Associated with Pulmonary Hypertension." International Journal of Molecular Sciences 22, no. 9 (May 7, 2021): 4980. http://dx.doi.org/10.3390/ijms22094980.
Conzelmann, Michael, Elena Rodionova, Michael Hess, Thomas Giese, Anthony D. Ho, Peter Dreger, and Thomas Luft. "Complementary JAK/STAT Signalling Is Required for the Pro-Inflammatory Effects of CD40 Ligation: Differential Effects in Human Myeloid and B Cells." Blood 110, no. 11 (November 16, 2007): 2413. http://dx.doi.org/10.1182/blood.v110.11.2413.2413.
Trivedi, Sunny, and Michelle Starz-Gaiano. "Drosophila Jak/STAT Signaling: Regulation and Relevance in Human Cancer and Metastasis." International Journal of Molecular Sciences 19, no. 12 (December 14, 2018): 4056. http://dx.doi.org/10.3390/ijms19124056.
Chen, Pei-Chi, Chen-Hsun Ho, Chia-Kwung Fan, Shih-Ping Liu, and Po-Ching Cheng. "Antimicrobial Peptide LCN2 Inhibited Uropathogenic Escherichia coli Infection in Bladder Cells in a High-Glucose Environment through JAK/STAT Signaling Pathway." International Journal of Molecular Sciences 23, no. 24 (December 12, 2022): 15763. http://dx.doi.org/10.3390/ijms232415763.
Bonjardim, C. A. "JAK/STAT-deficient cell lines." Brazilian Journal of Medical and Biological Research 31, no. 11 (November 1998): 1389–95. http://dx.doi.org/10.1590/s0100-879x1998001100004.
Rabadan, Raul, and Giorgio Inghirami. "JAK-STAT in lymphoproliferative disorders." Oncoscience 2, no. 9 (August 11, 2015): 737–38. http://dx.doi.org/10.18632/oncoscience.189.
Pernis, Alessandra B., and Paul B. Rothman. "JAK-STAT signaling in asthma." Journal of Clinical Investigation 109, no. 10 (May 15, 2002): 1279–83. http://dx.doi.org/10.1172/jci0215786.
Barwick, Benjamin G., and Sagar Lonial. "We need CD38 STAT-JAK." Blood 136, no. 20 (November 12, 2020): 2246–48. http://dx.doi.org/10.1182/blood.2020007467.
Rawlings, J. S. "The JAK/STAT signaling pathway." Journal of Cell Science 117, no. 8 (March 15, 2004): 1281–83. http://dx.doi.org/10.1242/jcs.00963.
Heinrich, Peter C., Serge Haan, Kevin W. Harris, Heike M. Hermanns, Silke Metz, Gerhard Müller-Newen, Fred Schaper, and Monique Wiesinger. "JAK/STAT signaling in cancer." Biomedicine & Pharmacotherapy 60, no. 8 (September 2006): 488. http://dx.doi.org/10.1016/j.biopha.2006.07.058.
Villarino, Alejandro V., Massimo Gadina, John J. O’Shea, and Yuka Kanno. "SnapShot: Jak-STAT Signaling II." Cell 181, no. 7 (June 2020): 1696–1696. http://dx.doi.org/10.1016/j.cell.2020.04.052.
Li, Jiliang. "JAK-STAT and bone metabolism." JAK-STAT 2, no. 3 (July 15, 2013): e23930. http://dx.doi.org/10.4161/jkst.23930.
Schindler, Christian. "Cytokines and JAK–STAT Signaling." Experimental Cell Research 253, no. 1 (November 1999): 7–14. http://dx.doi.org/10.1006/excr.1999.4670.